Targeting regulation of cyclin dependent kinase 9 as a novel therapeutic strategy in synovial sarcoma
Xiaoyang Li(University of Science and Technology of China), Zhenfeng Duan(Sylvester Comprehensive Cancer Center)
Cited by 23
Related Papers
Uncoupling DNA damage from chromatin damage to detoxify doxorubicin
|Proceedings of the National Academy of Sciences|2020|174
Targeting Cdk11 in osteosarcoma cells using the CRISPR‐cas9 system
|Journal of Orthopaedic Research®|2014|106
Targeting <i>ABCB1 (MDR1)</i> in multi-drug resistant osteosarcoma cells using the CRISPR-Cas9 system to reverse drug resistance
|Oncotarget|2016|88
The emerging roles and therapeutic potential of cyclin-dependent kinase 11 (CDK11) in human cancer
|Oncotarget|2016|74
SD-1029 Inhibits Signal Transducer and Activator of Transcription 3 Nuclear Translocation
|Clinical Cancer Research|2006|67